Rising Health Insurance Costs Due to Expiration of ACA Subsidies

Millions of Americans may face rising health insurance costs in 2026 due to the scheduled expiration of Affordable Care Act (ACA) subsidies at the end of December 2025. These tax credits have supported approximately 22 million Americans since 2021 by reducing their monthly premiums. The potential termination of these subsidies raises significant concerns for individual policyholders and might impact overall healthcare expenses within the industry.

Impact of Subsidy Expiration on Premiums

According to investment advisor SmartAsset, without enhanced subsidies, ACA plan holders would endure drastically higher premiums. In Mississippi, where ACA plans cover about 11% of the population, average monthly premiums could skyrocket from $41 to $605, a staggering increase of 1,376%. West Virginia enrollees are looking at a potential average rise of 1,058%. These projections highlight the potential financial strain on individual insurance payers and regulatory compliance requirements for providers.

Analysis and Legislative Challenges

SmartAsset's projections, based on the Centers for Medicare and Medicaid Services' 2025 Marketplace Open Enrollment data, indicate substantial cost increases without subsidies. Financial impacts will vary due to factors like specific insurance plans, age, household income, and geographical location. Current projections from KFF, a prominent health policy group, suggest ACA enrollees could see a 114% average annual increase in out-of-pocket premium costs.

The extension of these tax credits remains uncertain amid congressional challenges. While the House passed a healthcare bill with several Republican-supported policies, it omits ACA subsidies. Bipartisan efforts for a temporary three-year extension face obstacles, making the likelihood of legislative resolution minimal until the new year. The lapse of subsidies might lead to reduced assistance or loss of eligibility for some enrollees, impacting carriers, risk management, and potentially escalating regulatory disruptions in the insurance underwriting segment.